CESS from ATCC

Product Specs
ItemCESS
CompanyATCC
Price $551.00Supplier Page View Company Product Page
Catalog NumberTIB-190
ApplicationsCESS cells can be used to assay T-cell replacing factor (TRF)
TypeCell Biology
SpeciesHomo sapiens
TissueBlood
Cell LineCESS
Tissue (standardized)Blood
Cell Typelymphoblast
Ageadult
DiseaseMyelomonocytic Leukemia

Specifications/Features

Post freeze viability ≥ 50%

Add to Compare List

ATCC

10801 University Boulevard

Manassas, Virginia 20110-2209

United States

Phone: (703) 365-2700
Fax: (703) 365-2701

Company Profile

Website: http://www.atcc.org

(1) Integration of RNAseq transcriptomics and N-glycomics reveal biosynthetic pathways and predict structure-specific N-glycan expression†Chem SciApril 4, 2025Michael Russelle S. Alvarez, Xavier A. Holmes, Armin Oloumi, Sheryl Joyce Grijaldo-Alvarez, Ryan Schindler, Qingwen Zhou, Anirudh Yadlapati, Atit Silsirivanit, Carlito B. Lebrillaimmortalized lung cancer cell line, GLC01, in comparison to lung fibroblast cells CCD19-Lu and B cells Tib-190 (Fig. 5). GLC01 was recently immortalized by CDK4-insertion into primary cells derived from a patient

(2) Profiling Intact Glycosphingolipids with Automated Structural Annotation and Quantitation from Human Samples with Nanoflow Liquid Chromatography Mass SpectrometryAnalytical ChemistryApril 16, 2024Ryan L. Schindler, Armin Oloumi, Jennyfer Tena, Michael Russelle S. Alvarez, Yiyun Liu, Sheryl Grijaldo, Mariana Barboza, Lee-Way Jin, Angela M. Zivkovic, Carlito B. Lebrillasubject, age 93, with pathologically confirmed Alzheimer’s disease. Cell Culture CESS lymphoblast (TIB-190) cells were cultured in RPMI-1640 Medium (ATCC, Cat# 30–2001) containing 10% (v/v) fetal bovine serum

(3) Renin angiotensin system genes are biomarkers for personalized treatment of acute myeloid leukemia with Doxorubicin as well as etoposidePLOS ONENovember 25, 2020Seyhan Turk et al.purchased from Sigma Aldrich (St. Louis, Mo., USA), KASUMI-3 (CRL-2725), GDM-1 (CRL-2627) and CESS (TIB-190) cell lines were purchased from ATCC (Virginia, USA) and P31/FUJ (JCRB0091), NOMO-1 (IFO50474), KASUMI-1

(4) The impact of At1r inhibition via losartan on the anti-leukaemic effects of doxorubicin in acute myeloid leukaemiaJournal of the Renin-Angiotensin-Aldosterone SystemMay 24, 2019Mehdi Ghasemi, Mufide Okay, Seyhan Turk, Ronak Naeemaee, Ebru Guver, Umit Y Malkan, Salih Aksu, Nilgun Sayinalp, Ibrahim C Haznedarogluresulting protocol and other RAS-related pathways. Materials and methods Cell culture CESS (ATCC® TIB-190™), HL-60(ATCC® CCL-240™), NOMO-1, P31/FUJ, GDM-1(ATCC® CRL-2627™) and KASUMI-3 (ATCC® CRL-11147™) leukaemia

(5) EBV-miR-BHRF1-2 targets PRDM1/Blimp1: potential role in EBV lymphomagenesisLeukemiaMarch 1, 2016J Ma, K Nie, D Redmond, Y Liu, O Elemento, D M Knowles, W Tamclassified according to the World Health Organization 2008 classification. LCLs ARH77, CCL156, CCL159 and TIB-190 were purchased from ATCC (Manassas, VA, USA), and JY25 was previously described.23 These LCL cell lines

(6) Target DNA detection and quantitation on a single cell with single base resolutionTechnology (Singap World Sci)July 1, 2014Tania Konry, Adam Lerner, Martin L. Yarmush, Irina V. Smolinafrom human virus-associated malignancies, AIDS-related body-cavity-based lymphoma cell line and CESS (TIB-190), which are EBV-positive B lymphoblastic cell line derived from patients with myelomonocytic leukemia.

Be the First to Write a Review!

Description

Specifications/Features

ATCC

Citations (6)

Reviews

CESS from ATCC

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map